• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

A History of UK Aesthetic Firsts

A History of UK Aesthetic Firsts

Since opening on Harley Street in January 2014, PHI Clinic has more aesthetic technologies to the UK than any other clinic. From the first FDA-cleared energy device for acne (), to the first cold-fibre laser for all skin types (), to the world's first portable dual-wavelength resurfacing laser (), our role as a UK launch partner for global manufacturers has shaped how medicine is practised across the country.

This page documents that . It is in two parts: the devices PHI Clinic was first to bring to the UK, and the for which PHI Clinic has served as the UK launch venue or Key Leader anchor.

Why being first matters in medical aesthetics

When a leading device manufacturer a UK launch clinic, the is rarely about commercial reach. It is about credibility, safety standards, and the to use a new responsibly in its earliest days on the market.

Being selected as a UK launch means a has assessed the clinical governance, the experience of its lead practitioners, and its track record with comparable . For our patients, the is meaningful: when a treatment is introduced at PHI Clinic, it has been by clinicians who have been directly trained by the device's developers, often before the wider UK market has access to it.

That said, newer is not better. A core part of our is rigorously each new before recommending it. We introduce we believe genuinely improve patient outcomes, not simply because they are new.

Each of the devices below a UK first for PHI Clinic, with documented or launch dates and verifiable .

PHI Clinic introduced to the UK in January 2014, the first availability of the FDA-cleared treatment for permanent reduction of underarm sweat anywhere in the country. The launch coincided with PHI opening on Harley Street. Since then, our team has performed of miraDry procedures, building one of the most miraDry case series of any UK clinic.

uses energy to permanently eliminate the sweat and odour glands in the area. Two treatment sessions, spaced three months apart, are recommended to optimal results. Because the contain less than 2 percent of the body's sweat glands, treatment does not the body's natural .

PHI Clinic became the first UK clinic to install the Cutera laser system, as documented by Medicine magazine. in the UK by Sigmacon, the excel V two wavelengths, 532nm and 1064nm, in a single platform, treatment of conditions, benign lesions, and a wide spectrum of skin from one device. The system has since become a standard of care for treating vascular and pigmentation cases across the UK.

PHI Clinic was the first clinic in the UK to offer , the first and only FDA-cleared energy device for the treatment of mild, moderate, and severe acne. uses 1726nm laser energy to selectively sebaceous gland activity, acne at its source rather than symptoms.

PHI's role as the UK launch clinic 's position as a Key Opinion Leader for Cutera, manufacturer. In clinical studies, 87 percent of patients treated with saw at least half of their acne clear at six months following the protocol, a result class that has the treatment options available to UK acne beyond conventional topical and oral .

PHI Clinic was the first UK clinic to install , the first cold-fibre laser to FDA for all skin types and tones. Operating at a 2910nm wavelength, delivers a uniquely cold laser beam that minimises damage to the surrounding skin, significantly reducing the post-inflammatory risk associated with ablative laser in darker skin types.

The treatment is particularly valuable for patients with skin types IV to VI, who have been by ablative laser . In a single platform, sun damage, age spots, fine lines, pigmentation, uneven texture, scarring, and pores.

PHI Clinic was the first UK clinic to introduce , a jet system originally from micro-propulsion research at Seoul . delivers active ingredients into the dermis through a 150-micron nozzle at controlled depths between 0.2mm and 2.0mm, without traditional needles, and without creating open wounds.

The system offers two delivery modes. solution from a short distance, producing droplets that penetrate the skin barrier for superficial rejuvenation and enhanced active ingredient . places the device in direct with the skin to deeper into the dermis, with a effect that helps scar tissue and stretch marks.

is particularly for patients with needle phobia and for treatments where intradermal delivery improves outcomes, including skin rejuvenation, scar and stretch mark improvement, acne treatment support, and scalp and hair protocols.

In May 2025, PHI Clinic became the UK launch for , described by its as the world's first portable, laser. is the named UK Key Opinion Leader for the device, as in Aesthetics Journal and Consulting Room.

combines 1550nm and 1927nm wavelengths via proprietary technology, both wavelengths to be or simultaneously in a single pass. This means a single session can wrinkles, acne scars, pigmentation, melasma, and sun damage at skin depths, concerns that traditionally separate treatments or multiple devices.

Beyond being first to specific devices, PHI Clinic has been chosen by manufacturers as the UK launch venue for new technologies, and Dr Tapan Patel holds Key Opinion Leader positions across multiple advanced .

ResurFX: UK industry launch hosted at PHI Clinic, March 2015

In March 2015, Lumenis, the largest energy-based medical device for aesthetic, surgical, and ophthalmology applications, PHI Clinic as the UK launch venue for the ResurFX non-ablative laser system. The industry event was documented by The Harley Street Journal and included a live by , described in the as "a recognised industry leader for facial rejuvenation treatments."

uses a 1565nm fibre laser to deliver non-ablative skin resurfacing, stimulating collagen production with minimal . The choice of PHI Clinic as the launch venue, less than 18 months after the clinic opened, reflected the of Dr Tapan clinical in laser-based facial .

, Medical Director and founder of PHI Clinic, is a UK Key Leader for , the minimally laser skin tightening treatment performed using the Eufoton LASEmaR 1500, as announced in Aesthetics Journal. was featured on Channel 5's 10 Years Younger in 10 Days, with Dr Tapan Patel the procedure as the non-surgical doctor on the programme.

PHI Clinic has also hosted UK industry events for EndoliftX, the Endolift platform, with Dr Tapan Patel opening the on the device's clinical .

Beyond firsts, PHI Clinic houses one of the largest collections of medical of any clinic in the UK. The clinic across four floors at 102 Harley Street, comprising pods, theatres, laser rooms, and a dedicated training academy where international and global cosmetic brands come to learn or best practices in aesthetics.

This breadth of technology clinically. It allows our team to build genuinely treatment plans, from a wide range of (injectable, laser, ultrasound, radiofrequency, and regenerative) based on what is right for the individual rather than what is available in a device range.

PHI role as a UK launch partner is by the of our team. , our Medical Director and founder, is a Global Key Leader for Allergan (the of and Juvéderm®), a Key Opinion Leader for Cutera (the parent of and ), the named UK Key Leader for , and a UK Key Opinion Leader for . He has trained clinicians and was the first doctor to deliver an to members of the of Plastic Surgeons (BAAPS), at their annual in October 2018.

This concentration of Key Opinion Leadership across device manufacturers is part of why global brands consistently choose PHI Clinic as a UK launch partner. Bringing a new to market in a regulated aesthetics environment requires not just early access, but the to use it safely and from day one.

For patients, our of UK firsts into something practical: access to Advanced (Highly recommended Webpage), by clinicians who have been trained directly by the people who them.

It also means a more considered approach to . Because we work closely with manufacturers from the earliest stages of UK availability, our team has a deeper of which patients each technology is suited for, and equally, when it is not the right choice. That depth of experience the natural-looking, evidence-led results PHI Clinic is known for.

If you are considering an aesthetic treatment and would like to understand which option is most appropriate for you, a with our clinical team is the best point.

Frequently asked questions

PHI Clinic on Harley Street was the first clinic in the UK to offer AviClear, the world's first FDA-cleared energy device for the of mild, moderate, and severe acne.

miraDry, the FDA-cleared for permanent reduction of underarm sweat, became available to UK patients at PHI Clinic in January 2014.

PHI Clinic on Harley Street was the first UK clinic to install UltraClear, the first cold-fibre laser to receive FDA clearance for all skin types and tones.

PHI Clinic was the first UK clinic to introduce NovoJet, a needle-free jet system delivering active ingredients into the dermis at controlled depths through 150-micron technology.

PHI Clinic was the UK launch for Multifrax in May 2025, with Dr Tapan Patel as the named UK Key Leader for the device.

The Lumenis ResurFX fractional non-ablative laser system was launched to the UK industry at PHI Clinic on Harley Street in March 2015, with Dr Tapan Patel the live at the launch event.

select launch based on clinical governance, the of lead practitioners, and the track record with technologies. PHI Clinic's Medical Director, Dr Tapan Patel, holds Key Leader positions with Aesthetics, Cutera, Multifrax, and Endolift, and the clinic one of the largest medical device collections of any aesthetic practice in the UK.

Not automatically. At PHI Clinic, every new is rigorously before being into care. The fact that a device is new does not make it the right choice for every patient, and a core part of our process is identifying the treatment that genuinely fits each individual, regardless of whether it is the latest available.

can be booked by calling or via our online form. During your consultation, our clinical team will discuss your concerns and goals, and the approach best suited to you.

Disclaimer: Results may vary from person to person and treatment to treatment.

© 2024 PHI Clinic

© 2024 PHI Clinic